The higher dose led to a more rapid decline in an important marker of neurodegeneration, according to a Biogen news release ...

The results showed that 26% of patients who received tulisokibart achieved clinical remission at week 12 compared with 1% of ...

More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...

Sanjula Jain of Trilliant Health talks about how employers are best positioned to demand value for money from the U.S.

Early trial data of two virally suppressed, breast-feeding women with HIV shows that there may be less of a risk of HIV ...

A review of skeletal muscle relaxants shows that they don't work for pain from osteoarthritis, neuropathic pain and other ...

People living with HIV in neighborhoods that had been redlined by federal housing officials had a longer time interval ...

Arwen Podesta, M.D., discussed prescription digital therapeutics for people with mental health and substance abuse conditions ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Artificial intelligence is quickly becoming a valuable tool in the U.S. healthcare industry. Experts say a thoughtful ...

Preclinical data had suggested reducing serotonin might improve symptoms of pulmonary arterial hypertension, but new phase 2b ...

Sean M. Oser, M.D., M.P.H., an associate professor in the Department of Family Medicine at the University of Colorado School ...